Health
Potential inhibitors of SARS-CoV-2 identified – News-Medical.Net
Now, a new study published on the preprint server bioRxiv in August 2020 reports the discovery of two inhibitors of the helicase enzyme, which is essential for viral replication and the most highly conserved non-structural coronavirus (CoV) protein.
In the absence of an effective drug or vaccine, the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent which causes COVID-19, has been slow and ineffectual. Now, a new study by researchers at the University of Texas and published on the preprint server bioRxiv* in August 2020 reports the discovery of two inhibitors of the helicase enzyme, which is essential for viral replication and the most highly conserved non-structural coronavirus (CoV) protein.
Atomic Str…
-
Noosa News23 hours agoMajor flood arrives at Birdsville
-
Business8 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business24 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
General2 hours agoTony Armstrong and Courtney Act revealed as hosts of Australia’s 2025 Eurovision coverage